Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease

NCT00526630 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Gait Impairment

Interventions

DRUG: Methylphenidate (MPD)
DRUG: Placebo

Sponsor

University of Cincinnati

Collaborators

[object Object]